Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon - Beinema, Maarten; Brouwers, Jacobus R B J; Schalekamp, Tom; Wilffert, Bob (Thrombosis and haemostasis, 2008)
Keywords: Acenocoumarol - administration & dosage; Acenocoumarol - adverse effects; Acenocoumarol - pharmacokinetics; Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use; Anticoagulants - administration & dosage; Anticoagulants - adverse effects; Anticoagulants - pharmacokinetics; Aryl Hydrocarbon Hydroxylases - genetics; Aryl Hydrocarbon Hydroxylases - metabolism; Biotransformation; Blood Coagulation - drug effects; Cytochrome P-450 CYP2C9; Drug Interactions; Drug Monitoring; Hemorrhage - chemically induced; Humans; International Normalized Ratio; Mixed Function Oxygenases - genetics; Mixed Function Oxygenases - metabolism; Pharmacogenetics; Phenprocoumon - administration & dosage; Phenprocoumon - adverse effects; Phenprocoumon - pharmacokinetics; Polymorphism, Genetic; Risk Assessment; Vitamin K Epoxide Reductases; Warfarin - administration & dosage; Warfarin - adverse effects; Warfarin - pharmacokinetics